The growing interest in Bacopa monnieri extract for its calming properties is particularly noteworthy, especially considering its cognitive support benefits, contrasting with the memory-impairing effects associated with traditional benzodiazepine anxiolytics. Research comparing the calming effect of a standardized Bacopa monnieri extract to benzodiazepines found that Bacopa monnieri, at certain doses, showed a more significant calming effect in studies, highlighting its potential as a supportive supplement for cognitive and emotional well-being
A recent conference presentation summarized the anxiolytic profile of standardized Brahmi extract. Two batches of the extract were subjected to a number of CNS tests in animal models. The authors concluded that the mild anxiolytic effects exhibited by Brahmi extracts were partly responsible for the role of Brahmi in improving cognitive functions.
Standardized Brahmi extracts are noted for their cognitive-enhancing effects without the typical stimulant or depressant actions on the central nervous system. These extracts have been observed to extend sleep time when combined with barbiturates, enhance resilience under low oxygen conditions, mitigate aggressive behaviors, and diminish hyperactivity in specific animal models. Additionally, their ability to interfere with conditioned avoidance responses points to a potential for reducing anxiety, further supporting their role in cognitive health by promoting a balanced mental state.